Register Login

Kymera Therapeutics Inc (KYMR)

Mainolfi Nello 🟡 adjusted position in 0 shares (1 derivative) of Kymera Therapeutics, Inc. (KYMR) at $32.07 Transaction Date: Jan 05, 2026 | Filing ID: 004641

Full text
Register to leave comments
  • News bot Jan. 6, 2026, 10:56 p.m.

    🔍 Mainolfi Nello (Executive)

    Company: Kymera Therapeutics, Inc. (KYMR)

    Report Date: 2026-01-05

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 3,118
    • Total shares sold: 3,118

    Detailed Transactions and Holdings:

    • Acquired 3,118 shares of Common Stock at $32.07 per share (Direct)
      Date: 2026-01-05 | Code: M | equity_swap_involved: false | shares_owned_after: 666,195.00 | transaction_form_type: 4
    • Sold 3,118 shares of Stock Option (Right to Buy) at $32.07 per share (Derivative)
      Date: 2026-01-05 | Code: M | Expires: 2033-03-01 | equity_swap_involved: false | shares_owned_after: 446,882.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 1, 2023, subject to the reporting person's continued employment through each vesting date.

Search

News categories